KNSA
Kiniksa Pharmaceuticals International, plc
+1.28 (+1.66%)78.91USD189K成交股數6.5B市值86.7本益比(近四季)8.6股價營收比+55.5%營收年增(近四季)2026-10-27下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 214M+56% | 202M+80% | 181M+66% | 157M+96% | 138M+65% | 112M+67% | 109M+52% | 79.9M+65% | 83.4M | 67.0M | 71.5M | 48.3M |
| 營業成本 | 20.8M | 20.9M | 20.3M | 18.6M | 17.9M | 20.1M | 12.3M | 10.6M | 9.6M | 9.1M | 7.7M | 7.0M |
| 毛利 | 193M+61% | 181M+97% | 161M+67% | 138M+99% | 120M+62% | 92.1M+59% | 96.3M+51% | 69.3M+68% | 73.8M | 58.0M | 63.8M | 41.3M |
| 毛利率 | 90.3% | 89.6% | 88.8% | 88.1% | 87.0% | 82.1% | 88.7% | 86.7% | 88.5% | 86.4% | 89.2% | 85.4% |
| 研發費用 | 27.5M | 34.6M | 24.2M | 18.8M | 19.3M | 26.1M | 24.0M | 26.3M | 20.1M | 17.1M | 23.8M | 15.2M |
| 銷售管理費用 | 61.2M | 56.8M | 49.1M | 46.9M | 43.5M | 46.4M | 42.4M | 38.7M | 36.7M | 34.5M | 29.2M | 29.0M |
| 營業利益 | 29.3M+121% | 19.8M-305% | 24.0M-20631% | 20.2M-222% | 13.3M+16285% | −9.7M-12% | −117K-96% | −16.5M+48% | 81K | −10.9M | −3.2M | −11.2M |
| 營業利益率 | 13.7% | 9.8% | 13.3% | 12.9% | 9.6% | -8.6% | -0.1% | -20.7% | 0.1% | -16.3% | -4.4% | -23.2% |
| 稅後淨利 | 22.6M+165% | 14.2M-212% | 18.4M-572% | 17.8M-201% | 8.5M-66% | −12.7M-8% | −3.9M-126% | −17.7M+44% | 25.2M | −13.9M | 15.0M | −12.3M |
| 淨利率 | 10.5% | 7.0% | 10.2% | 11.4% | 6.2% | -11.3% | -3.6% | -22.2% | 30.3% | -20.7% | 20.9% | -25.4% |
| 稀釋 EPS | 0.27+145% | 0.18-200% | 0.23-483% | 0.23-192% | 0.11-70% | -0.18-10% | -0.06-129% | -0.25+39% | 0.37 | -0.20 | 0.21 | -0.18 |
| 稀釋股數 | 82.4M | 79.0M | 80.0M | 77.9M | 76.1M | 71.7M | 71.0M | 70.6M | 71.9M | 70.2M | 71.6M | 69.8M |
資產負債表 期末餘額
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 190M | 166M | 175M | 192M | 157M | 97.4M | 99.3M | 141M | 108M | 118M | 113M | 80.6M |
| 應收帳款 | 23.2M | 15.6M | 51.7M | 31.9M | 40.1M | 24.9M | 20.5M | 16.0M | 21.3M | 3.0M | 24.7M | 7.4M |
| 存貨 | 73.1M | 54.9M | 41.4M | 48.2M | 22.1M | 28.7M | 34.9M | 27.3M | 31.1M | 25.6M | 24.0M | 23.4M |
| 總資產 | 825M | 764M | 712M | 661M | 599M | 555M | 542M | 520M | 526M | 483M | 484M | 443M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 220M | 196M | 177M | 166M | 142M | 118M | 107M | 87.8M | 87.5M | 77.9M | 72.7M | 52.8M |
| 股東權益 | 606M | 568M | 535M | 495M | 457M | 437M | 435M | 432M | 439M | 405M | 412M | 390M |
| 負債比 | 26.6% | 25.7% | 24.8% | 25.1% | 23.7% | 21.3% | 19.8% | 16.9% | 16.6% | 16.1% | 15.0% | 11.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 50.2M+125% | – | – | – | 22.3M | – | – | 4.0M-193% | – | – | – | −4.3M |
| 資本支出 | 161K | – | – | – | 99K | – | – | 84K | – | – | – | 24K |
| 自由現金流 | 50.0M+125% | – | – | – | 22.2M | – | – | 3.9M-191% | – | – | – | −4.3M |
| 折舊攤銷 | 468K | – | – | – | 345K | – | – | 466K | – | – | – | 596K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | 23.4% | – | – | – | 16.1% | – | – | 4.9% | – | – | – | -8.9% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 678M
| 產品 | 678M | 100.0% | +62.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 678M | +60.1% | 59.0M | 8.7% | 0.75 | 136M |
| FY2024 | 423M | +56.6% | −43.2M | -10.2% | -0.60 | 25.4M |
| FY2023 | 270M | +22.7% | 14.1M | 5.2% | 0.20 | 13.2M |
| FY2022 | 220M | +471.2% | 183M | 83.3% | 2.60 | 5.7M |
| FY2021 | 38.5M | – | −158M | -409.7% | -2.30 | −127M |
| FY2020 | – | – | −161M | –% | -2.61 | −137M |
| FY2019 | – | – | −162M | –% | -2.99 | −162M |
| FY2018 | – | – | −103M | –% | -3.49 | −86.3M |